Janus Henderson Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $802K | Hold |
45,000
| – | – | ﹤0.01% | 1716 |
|
|
2025
Q1 | $848K | Sell |
45,000
-5,200
| -10% | -$98K | ﹤0.01% | 1701 |
|
|
2024
Q4 | $1.5M | Hold |
50,200
| – | – | ﹤0.01% | 1469 |
|
|
2024
Q3 | $784K | Hold |
50,200
| – | – | ﹤0.01% | 1791 |
|
|
2024
Q2 | $858K | Sell |
50,200
-10,200
| -17% | -$174K | ﹤0.01% | 1700 |
|
|
2024
Q1 | $943K | Buy |
60,400
+2
| +0% | +$31 | ﹤0.01% | 1675 |
|
|
2023
Q4 | $902K | Sell |
60,398
-125
| -0.2% | -$1.87K | ﹤0.01% | 1682 |
|
|
2023
Q3 | $977K | Buy |
60,523
+49,945
| +472% | +$806K | ﹤0.01% | 1566 |
|
|
2023
Q2 | $439K | Sell |
10,578
-1,166
| -10% | -$48.4K | ﹤0.01% | 2051 |
|
|
2023
Q1 | $706K | Sell |
11,744
-14,701
| -56% | -$884K | ﹤0.01% | 1821 |
|
|
2022
Q4 | $1.94M | Buy |
26,445
+4,297
| +19% | +$315K | ﹤0.01% | 1106 |
|
|
2022
Q3 | $1.68M | Buy |
22,148
+9,174
| +71% | +$697K | ﹤0.01% | 1383 |
|
|
2022
Q2 | $902K | Sell |
12,974
-1,222
| -9% | -$85K | ﹤0.01% | 1395 |
|
|
2022
Q1 | $1.18M | Sell |
14,196
-6,037
| -30% | -$500K | ﹤0.01% | 1427 |
|
|
2021
Q4 | $1.52M | Sell |
20,233
-36,134
| -64% | -$2.71M | ﹤0.01% | 1354 |
|
|
2021
Q3 | $6.55M | Buy |
56,367
+26,625
| +90% | +$3.09M | ﹤0.01% | 990 |
|
|
2021
Q2 | $6.6M | Sell |
29,742
-19,519
| -40% | -$4.33M | ﹤0.01% | 1004 |
|
|
2021
Q1 | $6.51M | Buy |
49,261
+43,647
| +777% | +$5.77M | ﹤0.01% | 970 |
|
|
2020
Q4 | $969K | Buy |
+5,614
| New | +$969K | ﹤0.01% | 1206 |
|